Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 187,491,552
  • Shares Outstanding, K 1,240,680
  • Annual Sales, $ 29,443 M
  • Annual Income, $ 8,510 M
  • EBIT $ 10,023 M
  • EBITDA $ 12,790 M
  • 60-Month Beta 0.36
  • Price/Sales 6.44
  • Price/Cash Flow 19.23
  • Price/Book 8.52

Options Overview Details

View History
  • Implied Volatility 28.28% (+0.73%)
  • Historical Volatility 32.90%
  • IV Percentile 39%
  • IV Rank 23.97%
  • IV High 49.97% on 04/08/25
  • IV Low 21.43% on 12/10/25
  • Expected Move (DTE 7) 4.39 (2.90%)
  • Put/Call Vol Ratio 1.10
  • Today's Volume 5,981
  • Volume Avg (30-Day) 13,281
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 172,100
  • Open Int (30-Day) 154,770
  • Expected Range 146.73 to 155.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.84
  • Number of Estimates 9
  • High Estimate 1.97
  • Low Estimate 1.69
  • Prior Year 1.81
  • Growth Rate Est. (year over year) +1.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.28 +23.59%
on 01/20/26
157.29 -3.92%
on 02/11/26
+26.21 (+20.98%)
since 01/16/26
3-Month
116.88 +29.30%
on 01/05/26
157.29 -3.92%
on 02/11/26
+23.05 (+18.00%)
since 11/19/25
52-Week
93.37 +61.85%
on 04/25/25
157.29 -3.92%
on 02/11/26
+43.47 (+40.38%)
since 02/19/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 155.00
2nd Resistance Point 153.91
1st Resistance Point 152.51
Last Price 151.12
1st Support Level 150.03
2nd Support Level 148.94
3rd Support Level 147.54

See More

52-Week High 157.29
Last Price 151.12
Fibonacci 61.8% 132.87
Fibonacci 50% 125.33
Fibonacci 38.2% 117.79
52-Week Low 93.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar